Esomeprazole inhibits liver inflammation and carcinogenesis by suppressing farnesoid x receptors and nf-κb signaling

HIGHLIGHTS

• What: The authors aimed to study the effects of on FXRs and in cells.
• Who: Lu CC from the Division of Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital Chiayi Branch, Taiwan Terry Fox Cancer Research Laboratory, Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan have published the Article: Esomeprazole inhibits liver inflammation and carcinogenesis by suppressing farnesoid X receptors and NF-κB signaling, in the Journal: (JOURNAL) of August/18,/2023
• How: For the cell model the authors used the human cell line HepaG2. For sub-confluent cultures HepG2 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.